These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 24614332)

  • 1. Reply: To PMID 24530602.
    Regueiro M; Kip KE; Baidoo L; Swoger JM; Schraut W
    Clin Gastroenterol Hepatol; 2014 Aug; 12(8):1407. PubMed ID: 24614332
    [No Abstract]   [Full Text] [Related]  

  • 2. Infliximab vs adalimumab for Crohn's disease.
    Dhillon AS; Harris AW
    Clin Gastroenterol Hepatol; 2015 Jan; 13(1):210. PubMed ID: 24954114
    [No Abstract]   [Full Text] [Related]  

  • 3. Infliximab vs adalimumab for Crohn's disease: perhaps too early to call it a tie.
    Dassopoulos T; Sorrentino D
    Clin Gastroenterol Hepatol; 2014 May; 12(5):818-20. PubMed ID: 24342747
    [No Abstract]   [Full Text] [Related]  

  • 4. Reply: To PMID 23811254.
    Osterman MT
    Clin Gastroenterol Hepatol; 2015 Jan; 13(1):210-1. PubMed ID: 25151256
    [No Abstract]   [Full Text] [Related]  

  • 5. Reply: To PMID 24440221.
    Regueiro M; Kip KE; Baidoo L; Swoger JM; Schraut W
    Clin Gastroenterol Hepatol; 2014 Oct; 12(10):1764-5. PubMed ID: 24956081
    [No Abstract]   [Full Text] [Related]  

  • 6. [Main therapeutic advances in IBD in 2007].
    Felley C; Mottet C; Maillard MH; Hess J; Delarive J; Michetti P
    Rev Med Suisse; 2008 Jan; 4(141):200, 202-4, 206-8 passim. PubMed ID: 18335885
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Adalimumab for the prevention and/or treatment of post-operative recurrence of Crohn's disease: a prospective, two-year, single center, pilot study.
    Papamichael K; Archavlis E; Lariou C; Mantzaris GJ
    J Crohns Colitis; 2012 Oct; 6(9):924-31. PubMed ID: 22424843
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The classics in perspective.
    Panés J; Ghosh S
    Gut; 2007 Sep; 56(9):1184-6. PubMed ID: 17698863
    [No Abstract]   [Full Text] [Related]  

  • 9. Association and management of Crohn's disease plus hidradenitis suppurativa.
    dos Santos CH; Netto PO; Kawaguchi KY; Parreira Alves JA; de Alencar Souza VP; Reverdito S
    Inflamm Bowel Dis; 2012 Apr; 18(4):E801-2. PubMed ID: 21993924
    [No Abstract]   [Full Text] [Related]  

  • 10. Editorial: adalimumab or infliximab as monotherapy, or in combination with an immunomodulator, in the treatment of Crohn's disease.
    Christensen B; Sparrow MP
    Aliment Pharmacol Ther; 2017 Jan; 45(1):178-179. PubMed ID: 27910149
    [No Abstract]   [Full Text] [Related]  

  • 11. Anti-tumor necrosis factor agents and placental transfer: relevant clinical data for rational decision-making.
    Kane S
    Clin Gastroenterol Hepatol; 2013 Mar; 11(3):293-4. PubMed ID: 23247325
    [No Abstract]   [Full Text] [Related]  

  • 12. Anti-TNF antibody therapy in Crohn's disease: the risk of a switch.
    Ricart E; Ordás I; Panés J
    Gut; 2012 Feb; 61(2):169-70. PubMed ID: 22068167
    [No Abstract]   [Full Text] [Related]  

  • 13. Issues surrounding postoperative therapy in Crohn's disease to prevent recurrence.
    Morar P; Hart A; Warusavitarne J
    Clin Gastroenterol Hepatol; 2014 Oct; 12(10):1763-4. PubMed ID: 24561509
    [No Abstract]   [Full Text] [Related]  

  • 14. Anti-tumor necrosis factor therapy to prevent Crohn's disease recurrence after surgery.
    Herfarth HH
    Clin Gastroenterol Hepatol; 2014 Sep; 12(9):1503-6. PubMed ID: 24534549
    [No Abstract]   [Full Text] [Related]  

  • 15. Reply: To PMID 23357488.
    Velayos F
    Clin Gastroenterol Hepatol; 2014 Feb; 12(2):346. PubMed ID: 24216468
    [No Abstract]   [Full Text] [Related]  

  • 16. Commentary: infliximab or adalimumab in Crohn's disease?
    Sprakes MB; Hamlin PJ
    Aliment Pharmacol Ther; 2012 Aug; 36(4):398. PubMed ID: 22803644
    [No Abstract]   [Full Text] [Related]  

  • 17. Letter: infliximab and adalimumab in the management of Crohn's disease--are they really comparable?
    Lopez-Sanroman A; Gisbert JP
    Aliment Pharmacol Ther; 2012 Sep; 36(5):498-9. PubMed ID: 22860615
    [No Abstract]   [Full Text] [Related]  

  • 18. Letter: are infliximab and adalimumab similar for Crohn's disease in clinical practice?
    Tursi A; Elisei W; Picchio M; Penna A
    Aliment Pharmacol Ther; 2013 Apr; 37(7):763-4. PubMed ID: 23458543
    [No Abstract]   [Full Text] [Related]  

  • 19. Adalimumab or infliximab for the prevention or treatment of post-operative recurrence in Crohn's disease.
    Yamamoto T
    J Crohns Colitis; 2013 May; 7(4):e157. PubMed ID: 23021875
    [No Abstract]   [Full Text] [Related]  

  • 20. Low-dose maintenance therapy with infliximab prevents postsurgical recurrence of Crohn's disease.
    Fraser GM
    Clin Gastroenterol Hepatol; 2010 Dec; 8(12):1099; author reply 1099-100. PubMed ID: 20728574
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.